Found: 114
Select item for more details and to access through your institution.
Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 211, doi. 10.1177/17407745231210872
- By:
- Publication type:
- Article
Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma.
- Published in:
- Sarcoma, 2014, p. 1, doi. 10.1155/2014/902620
- By:
- Publication type:
- Article
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.
- Published in:
- Journal of Surgical Oncology, 2016, v. 113, n. 4, p. 351, doi. 10.1002/jso.24145
- By:
- Publication type:
- Article
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00307-2
- By:
- Publication type:
- Article
Clinical development of new drugs for adults and children with cancer, 2010-2020.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 8, p. 917, doi. 10.1093/jnci/djad082
- By:
- Publication type:
- Article
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Pediatric Trials for Cancer Therapies With Targets Potentially Relevant to Pediatric Cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Impact of Tumor Mutational Burden in Neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 4, p. 389, doi. 10.1007/s40272-023-00568-9
- By:
- Publication type:
- Article
The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 2, p. 189, doi. 10.1007/s40272-020-00380-9
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of pediatric patients with desmoplastic small round cell tumor.
- Published in:
- Rare Tumors, 2016, v. 8, n. 1, p. 24, doi. 10.4081/rt.2016.6145
- By:
- Publication type:
- Article
Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1155, doi. 10.2967/jnumed.111.098624
- By:
- Publication type:
- Article
Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 843, doi. 10.1002/cam4.3658
- By:
- Publication type:
- Article
Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6658, doi. 10.1002/cam4.3349
- By:
- Publication type:
- Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 13, p. 4495, doi. 10.1002/cam4.3083
- By:
- Publication type:
- Article
Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution.
- Published in:
- Clinical Ophthalmology, 2013, v. 7, p. 981, doi. 10.2147/OPTH.S43398
- By:
- Publication type:
- Article
Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches.
- Published in:
- Sarcoma, 2018, p. 1, doi. 10.1155/2018/1712964
- By:
- Publication type:
- Article
Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/8758623
- By:
- Publication type:
- Article
Risk stratification by somatic mutation burden in Ewing sarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Enrollment on upfront high‐risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 7, p. 1, doi. 10.1002/pbc.31051
- By:
- Publication type:
- Article
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to <sup>131</sup>I-MIBG in patients with relapsed/refractory neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 1, p. 1, doi. 10.1002/pbc.30743
- By:
- Publication type:
- Article
Phase 1 study of cabozantinib in combination with topotecan–cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 12, p. 1, doi. 10.1002/pbc.30681
- By:
- Publication type:
- Article
Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30652
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30583
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30572
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Bone tumors.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30583
- By:
- Publication type:
- Article
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30572
- By:
- Publication type:
- Article
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 5, p. 1, doi. 10.1002/pbc.30106
- By:
- Publication type:
- Article
Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30054
- By:
- Publication type:
- Article
Pattern and predictors of sites of relapse in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 9, p. 1, doi. 10.1002/pbc.29616
- By:
- Publication type:
- Article
<sup>68</sup>Ga‐DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29740
- By:
- Publication type:
- Article
Anatomic patterns of relapse and progression following treatment with <sup>131</sup>I‐MIBG in relapsed or refractory neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 2, p. 1, doi. 10.1002/pbc.29396
- By:
- Publication type:
- Article
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 12, p. 1, doi. 10.1002/pbc.29333
- By:
- Publication type:
- Article
A case of metastatic adenocarcinoma of unknown primary in a pediatric patient: Opportunities for precision medicine.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28780
- By:
- Publication type:
- Article
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28834
- By:
- Publication type:
- Article
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 2, p. 1, doi. 10.1002/pbc.28807
- By:
- Publication type:
- Article
Landscape of phase 1 clinical trials for minors with cancer in the United States.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 11, p. 1, doi. 10.1002/pbc.28694
- By:
- Publication type:
- Article
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Trends in conditional survival and predictors of late death in neuroblastoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Second malignancies in patients treated for Ewing sarcoma: A systematic review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Winning the RACE: Expanding pediatric cancer drug approvals.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 9, p. 1, doi. 10.1002/pbc.27251
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article